OpenVSafe by OpenVAERS
Search V-safe

5CT-20727-17748

1 vaccination 1 coded response 7 check-ins 1 free-text entry 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
223 / VA
Registered
2021-01-05
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-05
    Registered in v-safe
  2. 2021-01-05
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-05
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Nausea · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-01-06
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  6. 2021-01-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-01-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-13
    Call successful
    Does not wish to fill out VAERS report
  10. 2021-01-19
    Survey response — day 14, dose 1
    MedDRA: Serum sickness — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Serum sickness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-19
    Report sent to call center — day 14, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  12. 2021-02-19
  13. 2022-01-05
    Health check-in — 12 months, dose 1
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-05Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-01-06 Successful
2021-01-13
Does not wish to fill out VAERS report
2021-01-19 Unsuccessful

Free text

Release 2 — day 14, dose 1

2021-01-19

Symptoms: Serum sickness

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDSerum sickness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release